Taking into consideration the aforementioned findings, it is obvious that KRAS represents a crucial target that links the tumor suppressor miR-143 and various types of cancers (cervical cancer, prostate cancer, CRC, breast cancer NSCLC). Here, KRAS is linked to breast cancer.